Evoke (LON:EVOK) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Evoke (LON:EVOKGet Free Report) had its target price upped by investment analysts at JPMorgan Chase & Co. from GBX 80 ($1.08) to GBX 82 ($1.11) in a note issued to investors on Thursday, Marketbeat reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective suggests a potential upside of 35.54% from the stock’s previous close.

Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 95 ($1.29) target price on shares of Evoke in a report on Wednesday.

Read Our Latest Stock Report on Evoke

Evoke Trading Down 1.3%

EVOK stock opened at GBX 60.50 ($0.82) on Thursday. The company has a market cap of £269.82 million, a price-to-earnings ratio of -1.51 and a beta of 0.84. Evoke has a 12 month low of GBX 36.70 ($0.50) and a 12 month high of GBX 77.80 ($1.05). The firm has a 50-day moving average of GBX 63.31 and a two-hundred day moving average of GBX 60.23.

Evoke (LON:EVOKGet Free Report) last released its quarterly earnings data on Wednesday, August 13th. The company reported GBX 1.20 ($0.02) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. As a group, equities analysts forecast that Evoke will post 12.7648305 earnings per share for the current year.

Insider Transactions at Evoke

In other news, insider Per Widerström acquired 68,958 shares of Evoke stock in a transaction that occurred on Friday, May 23rd. The shares were acquired at an average price of GBX 54 ($0.73) per share, with a total value of £37,237.32 ($50,470.75). Also, insider Sean Wilkins acquired 31,659 shares of Evoke stock in a transaction that occurred on Friday, May 23rd. The shares were purchased at an average cost of GBX 54 ($0.73) per share, for a total transaction of £17,095.86 ($23,171.40). 27.00% of the stock is currently owned by insiders.

Evoke Company Profile

(Get Free Report)

See Also

Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.